| scholarly article | Q13442814 |
| P50 | author | Douglas Mashek | Q42873871 |
| P2093 | author name string | Douglas G Mashek | |
| P2860 | cites work | SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism | Q24298588 |
| Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells | Q24301076 | ||
| Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity | Q24320035 | ||
| SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production | Q24611702 | ||
| Identification of a physiologically relevant endogenous ligand for PPARalpha in liver | Q24653691 | ||
| Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace | Q26858820 | ||
| Packaging of fat: an evolving model of lipid droplet assembly and expansion | Q27687575 | ||
| Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast | Q27939948 | ||
| The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | Q28190307 | ||
| Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene | Q28208142 | ||
| Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 | Q28209958 | ||
| Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 | Q28237795 | ||
| CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability | Q28245419 | ||
| Mammalian SIRT1 represses forkhead transcription factors | Q28246430 | ||
| Peroxisome proliferator-activated receptor alpha target genes | Q28248222 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology | Q28267844 | ||
| Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase | Q28283715 | ||
| Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c | Q28297047 | ||
| Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway | Q28505405 | ||
| FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice | Q28507512 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure | Q28510354 | ||
| The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR | Q28513664 | ||
| Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes | Q28565367 | ||
| A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels | Q28569762 | ||
| Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids | Q28573526 | ||
| Distinct ontogenic patterns of overt and latent DGAT activities of rat liver microsomes | Q28581274 | ||
| Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise | Q28581480 | ||
| Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells | Q28582601 | ||
| Hepatic histology in obese patients undergoing bariatric surgery | Q36561289 | ||
| In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats. | Q36586388 | ||
| Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease | Q36800964 | ||
| Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease | Q36856713 | ||
| The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals | Q36869039 | ||
| Dietary sugars stimulate fatty acid synthesis in adults | Q36898127 | ||
| Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice | Q37002642 | ||
| De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health | Q37088326 | ||
| Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. | Q37157342 | ||
| Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation | Q37189493 | ||
| Liver diseases and metabolic syndrome | Q37224466 | ||
| Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. | Q37250895 | ||
| Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort | Q37259440 | ||
| Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity | Q37297861 | ||
| Hepatic triacylglycerol accumulation and insulin resistance. | Q37321860 | ||
| Transcriptional regulation of mitochondrial glycerophosphate acyltransferase is mediated by distal promoter via ChREBP and SREBP-1 | Q37386374 | ||
| Mammalian fatty acid elongases | Q37393342 | ||
| Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease | Q37405640 | ||
| Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity | Q37431796 | ||
| FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states | Q37445714 | ||
| Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition | Q37459831 | ||
| Hepatic lipidosis in cats. | Q37518694 | ||
| Role of hepatic desaturases in obesity-related metabolic disorders | Q37786185 | ||
| Production, purification and characterization of adeno-associated vectors. | Q37807439 | ||
| Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis | Q37834857 | ||
| The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease | Q37925317 | ||
| The role of mitochondria in insulin resistance and type 2 diabetes mellitus | Q37930956 | ||
| The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease | Q37963122 | ||
| Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. | Q38008136 | ||
| Fatty acid-binding protein expression in the liver: its regulation and relationship to the zonation of fatty acid metabolism | Q38016357 | ||
| Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease | Q38072666 | ||
| Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 | ||
| Sirtuins' modulation of autophagy | Q38108575 | ||
| Regulation of autophagy by stress-responsive transcription factors | Q38111103 | ||
| Gene expression in human NAFLD. | Q38292078 | ||
| Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance | Q28583146 | ||
| Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein | Q28583188 | ||
| A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver | Q28583240 | ||
| Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis | Q28585179 | ||
| Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice | Q28589371 | ||
| The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice | Q28593453 | ||
| Mammalian mitochondrial glycerol-3-phosphate acyltransferase | Q28609581 | ||
| Genetic basis of mitochondrial HMG-CoA synthase deficiency | Q28624003 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease | Q29614897 | ||
| Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha | Q29620443 | ||
| Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase | Q30032295 | ||
| mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway | Q30425628 | ||
| Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling | Q30425815 | ||
| Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity | Q30433606 | ||
| Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression | Q30494849 | ||
| Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. | Q30541918 | ||
| Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation | Q33235063 | ||
| Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly | Q33537983 | ||
| Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. | Q33613991 | ||
| Role of acylCoA binding protein in acylCoA transport, metabolism and cell signaling | Q33637219 | ||
| A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis | Q33673834 | ||
| Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c | Q33785270 | ||
| Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice | Q33852162 | ||
| Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species | Q33901997 | ||
| Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. | Q33953637 | ||
| Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis | Q34021724 | ||
| Uptake of individual free fatty acids by skeletal muscle and liver in man | Q34074225 | ||
| Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia | Q34094336 | ||
| Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease | Q34101705 | ||
| Liver fatty acid-binding protein and obesity | Q34120131 | ||
| Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver | Q34125393 | ||
| FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase | Q34149531 | ||
| Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states | Q46921367 | ||
| Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. | Q47919939 | ||
| ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver | Q50336015 | ||
| Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. | Q50665949 | ||
| A role for seipin in lipid droplet dynamics and inheritance in yeast. | Q50669487 | ||
| Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. | Q51353898 | ||
| Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. | Q51375339 | ||
| Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. | Q51379331 | ||
| Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease. | Q51475558 | ||
| Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. | Q51495818 | ||
| Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. | Q51523783 | ||
| Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. | Q51573455 | ||
| Factors affecting liver uptake of serum free stearic acid-1-C14. | Q51692999 | ||
| Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. | Q51838864 | ||
| Evaluation of the affinity and turnover number of both hepatic mitochondrial and microsomal carnitine acyltransferases: relevance to intracellular partitioning of acyl-CoAs. | Q52083229 | ||
| Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. | Q53224130 | ||
| Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. | Q53485669 | ||
| Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. | Q53555710 | ||
| Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. | Q54191086 | ||
| Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. | Q54495638 | ||
| Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver | Q57016669 | ||
| Nonalcoholic Fatty Liver Disease in Severely Obese Subjects | Q58816508 | ||
| Spillover of Dietary Fatty Acids and Use of Serum Nonesterified Fatty Acids for the Synthesis of VLDL-Triacylglycerol Under Two Different Feeding Regimens | Q59487259 | ||
| Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity | Q64377000 | ||
| The hepatic uptake of individual free fatty acids in sheep during noradrenaline infusion | Q66950215 | ||
| Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes | Q67993662 | ||
| Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase | Q68082700 | ||
| Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis | Q69499133 | ||
| A Substrate- and Position-specific Acylation of sn-Glycerol 3-Phosphate by Rat Liver Mitochondria | Q70504237 | ||
| Significance of Adipose Tissue and Liver as Sites of Fatty Acid Synthesis in the Pig and the Efficiency of Utilization of Various Substrates for Lipogenesis | Q71235790 | ||
| Inhibition of liver microsomal carnitine acyltransferases by sulphonylurea drugs | Q72052203 | ||
| Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies | Q72133666 | ||
| Lipogenesis in the pigeon: in vivo studies | Q72227352 | ||
| Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells | Q72571322 | ||
| Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol | Q73053122 | ||
| Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A | Q73064677 | ||
| Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice | Q74061464 | ||
| UPTAKE OF PLASMA FREE FATTY ACIDS BY THE ISOLATED RAT LIVER: EFFECT OF GLUCAGON | Q76554494 | ||
| Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes | Q77313684 | ||
| Vectorial acylation: linking fatty acid transport and activation to metabolic trafficking | Q80685047 | ||
| Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease | Q85410881 | ||
| Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins | Q93629800 | ||
| Comparative aspects of lipogenesis in mammalian tissues | Q93814281 | ||
| Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways | Q34188050 | ||
| CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance | Q34188075 | ||
| Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation? | Q34215212 | ||
| Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals | Q34236856 | ||
| Splanchnic lipolysis in human obesity | Q34328357 | ||
| Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents | Q34355263 | ||
| Disordered lipid metabolism and the pathogenesis of insulin resistance | Q34370965 | ||
| Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. | Q34451430 | ||
| Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome | Q34503398 | ||
| Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning | Q34511046 | ||
| Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion | Q34651716 | ||
| Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy | Q34742779 | ||
| Hepatic Hepatocyte Nuclear Factor 4α Is Essential for Maintaining Triglyceride and Cholesterol Homeostasis | Q34812700 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| Biochemical and physiological function of stearoyl-CoA desaturase | Q34898764 | ||
| Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. | Q34935273 | ||
| Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids | Q34989773 | ||
| Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. | Q35186665 | ||
| Obesity, insulin resistance and free fatty acids | Q35204838 | ||
| Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling | Q35235426 | ||
| New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. | Q35855938 | ||
| Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows | Q35891776 | ||
| Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. | Q35897072 | ||
| Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. | Q35913725 | ||
| Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene | Q35922205 | ||
| Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver | Q35958436 | ||
| The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2 | Q35958448 | ||
| FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c | Q36016844 | ||
| Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation | Q36145221 | ||
| Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly | Q36339529 | ||
| Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition? | Q36438823 | ||
| Cellular fatty acid uptake: the contribution of metabolism | Q36470872 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. | Q38309701 | ||
| Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance | Q38314419 | ||
| Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice | Q38323956 | ||
| PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. | Q38332175 | ||
| Influence of Dietary Lipid on Lipogenic Enzyme Activities in Coho Salmon, Oncorhynchus kisutch (Walbaum) | Q39145371 | ||
| Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism | Q39193322 | ||
| Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells | Q39322543 | ||
| mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. | Q39616865 | ||
| Caloric Homeostasis and Disorders of Fuel Transport | Q39919368 | ||
| Gluconeogenesis and lipogenesis in tissue from ruminant and nonruminant animals | Q39977411 | ||
| Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice | Q40041201 | ||
| Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of long-chain fatty acids bound to albumin | Q40386781 | ||
| Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. | Q40477651 | ||
| Triacylglycerol hydrolase is localized to the endoplasmic reticulum by an unusual retrieval sequence where it participates in VLDL assembly without utilizing VLDL lipids as substrates. | Q40480335 | ||
| A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis | Q40691066 | ||
| The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis | Q40769306 | ||
| Lipoprotein metabolism and fattening in poultry | Q41481264 | ||
| Intracellular degradation of newly synthesized apolipoprotein B. | Q41646693 | ||
| Autophagy-lysosomal pathway is involved in lipid degradation in rat liver. | Q41929863 | ||
| FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes | Q42131271 | ||
| Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
| AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. | Q42468549 | ||
| Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice | Q42508123 | ||
| Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter | Q42835179 | ||
| Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals | Q42946610 | ||
| Metabolic fate of oleic acid, palmitic acid and stearic acid in cultured hamster hepatocytes | Q42982648 | ||
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
| The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways | Q43564087 | ||
| Fatty acid biosynthesis in liver and adipose tissue from dogs | Q43987761 | ||
| A species comparison of liver slice synthesis and secretion of triacylglycerol from nonesterified fatty acids in media | Q44089541 | ||
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
| Long-term follow-up of patients with nonalcoholic fatty liver | Q44431564 | ||
| Short communication: Net uptake of nonesterified long chain fatty acids by the perfused caudate lobe of the caprine liver | Q44437158 | ||
| Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. | Q44477314 | ||
| Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease | Q44664390 | ||
| Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice | Q44680979 | ||
| Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease | Q44726439 | ||
| Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes | Q45168907 | ||
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms | Q45300618 | ||
| LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. | Q45982093 | ||
| Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets | Q46121875 | ||
| Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease | Q46215726 | ||
| Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. | Q46442905 | ||
| Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans | Q46579067 | ||
| Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis | Q46660978 | ||
| Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus | Q46667867 | ||
| Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease | Q46872820 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 697-710 | |
| P577 | publication date | 2013-11-06 | |
| P1433 | published in | Advances in Nutrition | Q20821073 |
| P1476 | title | Hepatic fatty acid trafficking: multiple forks in the road | |
| P478 | volume | 4 |
| Q64073539 | Autophagy regulates lipid metabolism through selective turnover of NCoR1 |
| Q38629513 | Change in the Lipid Transport Capacity of the Liver and Blood during Reproduction in Rats |
| Q55001898 | Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Induces Long-Lasting Changes in Liver Metabolism in Male Mice. |
| Q57191699 | Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Permanently Alters Blood-Liver Balance of Lipids in Male Mice |
| Q55443852 | Direct effects of thyroid hormones on hepatic lipid metabolism. |
| Q53742808 | Effects of selenium on apoptosis and abnormal amino acid metabolism induced by excess fatty acid in isolated rat hepatocytes. |
| Q93106586 | Evolution, dynamic expression changes and regulatory characteristics of gene families involved in the glycerophosphate pathway of triglyceride synthesis in chicken (Gallus gallus) |
| Q39775282 | FABP-1 gene ablation impacts brain endocannabinoid system in male mice. |
| Q34538205 | FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein |
| Q39175553 | Fabp1 gene ablation inhibits high-fat diet-induced increase in brain endocannabinoids. |
| Q33613330 | Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias |
| Q91551847 | Fatty liver diseases, mechanisms, and potential therapeutic plant medicines |
| Q92694745 | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis |
| Q91825128 | Hepatic gene expression explains primary drug toxicity in bipolar disorder |
| Q47152443 | Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice |
| Q91814210 | High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths |
| Q47642289 | High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine. |
| Q41991541 | Host-derived fatty acids activate type VII secretion in Staphylococcus aureus |
| Q38839502 | Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids |
| Q39253589 | Lipid droplets and liver disease: from basic biology to clinical implications. |
| Q59340375 | Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration |
| Q96953670 | Long Non-coding RNA and mRNA Profile of Liver Tissue During Four Developmental Stages in the Chicken |
| Q38672086 | Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance |
| Q35237415 | MALDI Mass Spectrometry Imaging of Lipids and Gene Expression Reveals Differences in Fatty Acid Metabolism between Follicular Compartments in Porcine Ovaries |
| Q57054651 | Maternal cinnamon intake during lactation led to visceral obesity and hepatic metabolic dysfunction in the adult male offspring |
| Q59792894 | MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis |
| Q89220189 | Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease |
| Q53601277 | Oxidized tea polyphenols prevent lipid accumulation in liver and visceral white adipose tissue in rats. |
| Q91657975 | Pathogenesis of Nonalcoholic Steatohepatitis: An Overview |
| Q38848698 | Perinatal maternal high-fat diet promotes alterations in hepatic lipid metabolism and resistance to the hypolipidemic effect of fish oil in adolescent rat offspring |
| Q92322603 | SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC |
| Q55211136 | Selected Physiological Effects of a Garcinia Gummi-Gutta Extract in Rats Fed with Different Hypercaloric Diets. |
| Q92473797 | Selective Trafficking of Fatty Acids in the Liver: Add Them2 to the List of Influencers |
| Q90288831 | The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state |
| Q88214123 | Transcriptomic Analysis of Gonadal Adipose Tissue in Male Mice Exposed Perinatally to 2,2',4,4'-Tetrabromodiphenyl Ether (BDE-47) |
Search more.